UnitedHealth (UNH) Reports Q4 Earnings: What Key Metrics Have to Say

UnitedHealth Group (UNH) reported $113.22 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 12.3%. EPS of $2.11 for the same period compares to $6.81 a year ago.The reported revenue represents a surprise of -0.04% over the Zacks Consensus Estimate of $113.26 billion. With the consensus EPS estimate being $2.09, the EPS surprise was +0.83%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how UnitedHealth performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Operating Statistics - Medical Care Ratio: 92.4% versus the eight-analyst average estimate of 92.2%.UnitedHealthcare Customer Profile - People Served - Total Commercial - Domestic: 29.65 million versus the five-analyst average estimate of 30.02 million.UnitedHealthcare Customer Profile - People Served - Commercial - Domestic - Risk-based: 8.17 million versus 8.45 million estimated by five analysts on average.UnitedHealthcare Customer Profile - People Served - Commercial - Domestic - Fee-based: 21.49 million versus 21.57 million estimated by five analysts on average.Revenues- Products: $13.48 billion versus the eight-analyst average estimate of $13.86 billion. The reported number represents a year-over-year change of +0.1%.Revenues- UnitedHealthcare- Employer & Individual- Global: $861 million versus the eight-analyst average estimate of $829.74 million. The reported number represents a year-over-year change of +11.1%.Revenues- Services: $10.27 billion versus $9.47 billion estimated by eight analysts on average. Compared to the year-ago quarter, this number represents a +10.5% change.Revenues- Premiums: $88.81 billion compared to the $88.99 billion average estimate based on eight analysts. The reported number represents a change of +16.1% year over year.Revenues- Investment and other income: $647 million compared to the $1.11 billion average estimate based on eight analysts. The reported number represents a change of -58.3% year over year.Revenues- Optum Health: $25.54 billion compared to the $25.4 billion average estimate based on six analysts. The reported number represents a change of -0.5% year over year.Revenues- UnitedHealthcare- Total: $87.11 billion compared to the $87.3 billion average estimate based on six analysts. The reported number represents a change of +17.5% year over year.Revenues- Optum Insight: $5.04 billion versus $4.94 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +5.5% change.View all Key Company Metrics for UnitedHealth here>>>Shares of UnitedHealth have returned +6.9% over the past month versus the Zacks S&P 500 composite's +0.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Just Released: Zacks Top 10 Stocks for 2026Hurry – you can still get in early on our 10 top tickers for 2026. Handpicked by Zacks Director of Research Sheraz Mian, this portfolio has been stunningly and consistently successful.From inception in 2012 through November, 2025, the Zacks Top 10 Stocks gained +2,530.8%, more than QUADRUPLING the S&P 500’s +570.3%.Sheraz has combed through 4,400 companies covered by the Zacks Rank and handpicked the best 10 to buy and hold in 2026. You can still be among the first to see these just-released stocks with enormous potential.See New Top 10 Stocks >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report UnitedHealth Group Incorporated (UNH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks